Počet záznamov: 1
denosumab
SYS d000069448 LBL 00000nz--a2200181n--4500 005 20250606221747.3 008 160101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D12.776.124.486.485.114.224.060.782 065 $a D12.776.124.790.651.114.224.060.782 065 $a D12.776.377.715.548.114.224.200.782 066 $a 01 $c 03 150 $a denosumab $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $2 slo 450 $w v $a AMG 162 $2 slo 550 $7 sllk_us_auth*d053245 $Y RANK Ligand $w b $a RANK ligand 550 $7 sllk_us_auth*d050071 $Y Bone Density Conservation Agents $w P $a látky pôsobiace pozitívne na kostnú denzitu 550 $7 sllk_us_auth*d053245 $Y RANK Ligand $w p $a RANK ligand 665 $a 2016 (2004) $2 eng 680 9-
$i A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS. $2 eng 750 -2
$a Denosumab $2 eng 980 $x M
Počet záznamov: 1